Facebook
Twitter
Telegram
Report an ErrorHeat Biologics, Inc. Financial Statements 2011-2024 | HTBX
Annual Financial Statements Heat Biologics, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Market Cap |
32.8 M | 8.32 M | 24.8 M | 10.9 M | 17.8 M | 19.9 M | 37.1 M | 28.5 M | - | - |
Shares |
4.75 M | 4.75 M | 2.5 M | 549 K | 255 K | 116 K | 93.4 K | 54.2 K | - | - |
Net Income |
-26 M | -20 M | -15.7 M | -11.8 M | -12.6 M | -20.3 M | -11.8 M | -8.71 M | -2.42 M | -2.1 M |
Revenue |
2.95 M | 3.05 M | 5.79 M | 1.52 M | 342 K | - | - | - | 3.11 K | 188 K |
EBITDA |
-24.7 M | -19.2 M | -17.2 M | -13 M | -13 M | -20.9 M | -12.1 M | -6.56 M | -2.34 M | -2.03 M |
Operating Expenses |
27.9 M | 22.4 M | 23.3 M | 14.6 M | 13.5 M | 21 M | 12.2 M | 6.56 M | 2.35 M | 2.22 M |
General and Administrative Expenses |
15 M | 9.43 M | 7.03 M | - | 4.14 M | - | - | - | - | - |
All numbers in USD currency